服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-SARS-CoV-2 Spike RBD mAbs [Tixagevimab Biosimilar] (MABL-5332) | MABL-5332 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD3E;CLDN18 mAbs [Tixentamig Biosimilar] (MABL-5333) | MABL-5333 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Lambda;na |
| Anti-TNFRSF7/CD27 mAbs [Tixestobart Biosimilar] (MABL-5334) | MABL-5334 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-TACSTD2/TROP2/EGP1 mAbs [Tizetatug Biosimilar] (MABL-5335) | MABL-5335 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDCD1/CD279/PD1;LAG3/CD223 mAbs [Tobemstomig Biosimilar] (MABL-5336) | MABL-5336 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-Human Papillomavirus Envelope Protein mAbs [Tobevibart Biosimilar] (MABL-5337) | MABL-5337 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-IL6R/CD126 mAbs [Tocilizumab Biosimilar] (MABL-5338) | MABL-5338 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CLEC12A;CD3E mAbs [Tepoditamab Biosimilar] (MABL-5307) | MABL-5307 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-IGF1R/CD221 mAbs [Teprotumumab Biosimilar] (MABL-5308) | MABL-5308 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-HIV-1 gp120 CD4bs mAbs [Teropavimab Biosimilar] (MABL-5309) | MABL-5309 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-C5 mAbs [Tesidolumab Biosimilar] (MABL-5310) | MABL-5310 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-KLRK1/NKG2D/CD314 mAbs [Tesnatilimab Biosimilar] (MABL-5311) | MABL-5311 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-TSLP mAbs [Tezepelumab Biosimilar] (MABL-5312) | MABL-5312 | ELISA, FACS, Functional assay, in vivo binding | G2, Lambda |
| Anti-TNFSF13B/CD257/BAFF;IL17A mAbs [Tibulizumab Biosimilar] (MABL-5313) | MABL-5313 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;Kappa |
| Anti-SSTR2;CD3E mAbs [Tidutamab Biosimilar] (MABL-5314) | MABL-5314 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Lambda |
| Anti-BTLA/CD272 mAbs [Tifcemalimab Biosimilar] (MABL-5315) | MABL-5315 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-TNFRSF10B/CD262/DR5/TRAILR2 mAbs [Tigatuzumab Biosimilar] (MABL-5316) | MABL-5316 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MET/HGFR;EGFR/ERBB1/HER1 mAbs [Tilatamig Biosimilar] (MABL-5317) | MABL-5317 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Lambda |
| Anti-MAPT mAbs [Tilavonemab Biosimilar] (MABL-5318) | MABL-5318 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL23A mAbs [Tildrakizumab Biosimilar] (MABL-5319) | MABL-5319 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn